Vascular factors in Alzheimer's disease:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York, NY
New York Acad. of Sciences
2000
|
Schriftenreihe: | New York Academy of Sciences: Annals of the New York Academy of Sciences
903 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XIX, 556 S. Ill., graph. Darst. |
ISBN: | 1573312517 1573312525 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV013255900 | ||
003 | DE-604 | ||
005 | 20000724 | ||
007 | t | ||
008 | 000718s2000 ad|| |||| 10||| eng d | ||
020 | |a 1573312517 |9 1-57331-251-7 | ||
020 | |a 1573312525 |9 1-57331-252-5 | ||
035 | |a (OCoLC)43483720 | ||
035 | |a (DE-599)BVBBV013255900 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-20 |a DE-12 |a DE-355 |a DE-578 | ||
050 | 0 | |a Q11 | |
050 | 0 | |a RC523 | |
082 | 0 | |a 616.8/3107 |2 21 | |
082 | 0 | |a 500 |2 21 | |
084 | |a YG 4037 |0 (DE-625)153494:12944 |2 rvk | ||
245 | 1 | 0 | |a Vascular factors in Alzheimer's disease |c ed. by Raj N. Kalaria ... |
264 | 1 | |a New York, NY |b New York Acad. of Sciences |c 2000 | |
300 | |a XIX, 556 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a New York Academy of Sciences: Annals of the New York Academy of Sciences |v 903 | |
650 | 4 | |a Accidents vasculaires cérébraux - Physiopathologie - Congrès | |
650 | 4 | |a Alzheimer, Maladie d' - Physiopathologie - Congrès | |
650 | 4 | |a Cerveau - Vaisseaux sanguins - Congrès | |
650 | 7 | |a Vaatziekten |2 gtt | |
650 | 7 | |a Ziekte van Alzheimer |2 gtt | |
650 | 4 | |a Alzheimer Disease |x etiology |v Congresses | |
650 | 4 | |a Alzheimer Disease |x physiopathology |v Congresses | |
650 | 4 | |a Alzheimer's disease |x Pathophysiology |v Congresses | |
650 | 4 | |a Brain |x Blood-vessels |v Congresses | |
650 | 4 | |a Cerebral Amyloid Angiopathy |v Congresses | |
650 | 4 | |a Cerebrovascular Disorders |x physiopathology |v Congresses | |
650 | 4 | |a Cerebrovascular disease |x Pathophysiology |v Congresses | |
650 | 4 | |a Dementia |x etiology |v Congresses | |
650 | 4 | |a Dementia |x physiopathology |v Congresses | |
650 | 0 | 7 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Amyloidose |0 (DE-588)4142314-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pathophysiologie |0 (DE-588)4044898-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hirngefäßkrankheit |0 (DE-588)4025015-5 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1999 |z Newcastle-upon-Tyne |2 gnd-content | |
689 | 0 | 0 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |D s |
689 | 0 | 1 | |a Pathophysiologie |0 (DE-588)4044898-8 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Hirngefäßkrankheit |0 (DE-588)4025015-5 |D s |
689 | 1 | 1 | |a Pathophysiologie |0 (DE-588)4044898-8 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |D s |
689 | 2 | 1 | |a Amyloidose |0 (DE-588)4142314-8 |D s |
689 | 2 | |5 DE-604 | |
689 | 3 | 0 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |D s |
689 | 3 | 1 | |a Hirngefäßkrankheit |0 (DE-588)4025015-5 |D s |
689 | 3 | |5 DE-604 | |
700 | 1 | |a Kalaria, Raj N. |e Sonstige |4 oth | |
830 | 0 | |a New York Academy of Sciences: Annals of the New York Academy of Sciences |v 903 |w (DE-604)BV002532608 |9 903 | |
856 | 4 | 2 | |m Digitalisierung TU Muenchen |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009035838&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-009035838 |
Datensatz im Suchindex
_version_ | 1804128019726467072 |
---|---|
adam_text | ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Volume
903
April
2000
VASCULAR FACTORS IN
ALZHEIMER S DISEASE0
Editors and Conference Chairs
Raj
N.
Kalaria and Paul
Ince
CONTENTS
Henryk Mirosław Wiśniewski,
1931-1999.
By
R.N.
Kalaria
and
A.E.
Oakley
................................................. xiii
Preface. By Raj
N.
Kalaria
......................................... xvii
Part I. Alzheimer s Disease: Vascular Concepts, Cellular Issues,
and Genetics (Plenary Lectures)
Vascular Factors in Cognitive Impairment
—
Where Are We Now? By
Vladimir Hachinski and David Munoz
....................... 1
Role of Perivascular Cells and Myocytes in Vascular Amyloidosis. By
H.M.
Wiśniewski,
J.
Węgiel,
A. W. Vorbrodt, B. Mazur-Kolecka,
AND J. FRACKOWIAK
.......................................... 6
Binswanger Disease: The History of a Silent Epidemic. By GUSTAVO C.
Román
...................................................... 19
Cascading
Glia
Reactions: a Common Pathomechanism and Its Differentiat¬
ed Control by Cyclic Nucleotide Signaling. By Peter Schubert,
Tadao Morino, Hirofumi
Miyazaki, Tadanori
Ogata, Yoichi
Nakamura,
Cristina Marchini,
and
Stefano Ferroni......... 24
Part II. Vascular Pathology in Alzheimer s Disease:
Recent Developments
Linguistic Ability in Early Life and the Neuropathology of Alzheimer s
Disease and Cerebrovascular Disease: Findings from the Nun Study. By
D.A. Snowdon, L.H. Greiner, and W.R. Markesbery
......... 34
Cerebrovascular Pathology in Alzheimer s Disease and Leukoaraiosis. By
William R. Brown, Dixon M. Moody, Clara R.
Thore,
and
Venkata R.
Challa
.......................................... 39
This volume contains the papers from a conference entitled Vascular Factors in Alzheimer s
Disease, which was held in Slaley Hall, near Newcastle upon Tyne, UK on May
25-28, 1999.
Role of Blood Vessels in Producing Pathological Changes in the Brain with
Alzheimer s Disease. By Taihei Miyakawa, Takemi Kimura,
Shinichi Hirata, Noboru Fujise, Tsunehiko
Ono,
Koko Ishizuka,
and
Jun Nakabayashi
........................ 46
Cerebrovasculature-mediated
Neuronal
Cell Death. By Paula Grammas,
Ulrich Reimann-Philipp,
and Paul H. Weigel
................. 55
Role of Aberrant Nitric Oxide Synthase-3 Expression in Cerebrovascular
Degeneration and Vascular-mediated Injury in Alzheimer s Disease.
By
Suzanne M. de
la Monte, Yoon K.
Sohn,
Dannie
Etienne,
Joanny
Kraft, and Jack
R.
Wands
........................... 61
Similar
Ultrastructural
Breakdown of Cerebrocortical Capillaries in
Alzheimer s Disease, Parkinson s Disease, and Experimental Hyper¬
tension: What is the Functional Link? By
Eszter Farkas, Gineke
I. De
Jong,
Etelka Apró,
Rob A.I.
De Vos, Ernst N.H.
Jansen Steur,
and Paul G.M. Luiten
................................. 72
Distribution of Amyloid
ß42 in
Relation to the Cerebral Microvasculature in
an Elderly Cohort with Alzheimer s Disease. By A.J. THOMAS,
CM. Morris, I.N. Ferrier, and R.N. Kalaria
.................. 83
Part
Ш.
Cerebral Amyloid Angiopathy and Factors Regulating
Cerebral Amyloidosis
Cerebrovascular Smooth Muscle Cell Surface
Fibrillar
Aß:
Alteration of the
Proteolytic Environment in the Cerebral Vessel Wall. By William E.
Van Nostrand, Jerry
Melchor,
Matthew Wagner, and
Judianne Davis
.............................................. 89
Aß Vasoactivity:
An Inflammatory Reaction. By Daniel Paris,
Terrence Town, Timothy Parker, James Humphrey, and
Michael
Mullan
............................................ 97
Cerebral Amyloid Angiopathy: Accumulation of
Aß in
Interstitial Fluid
Drainage Pathways in Alzheimer s Disease. By ROY O. Weller,
Adrian Massey, Yu-Min Kuo, and Alex E.
Roher.............
HO
Traumatic Brain Injury Elevates the Alzheimer s Amyloid
Peptide
Aß42 in
Human CSF: A Possible Role for Nerve Cell Injury. By M.R.
Emmerling, M.C. Morganti-Kossmann, T. Kossmann,
P. F. Stahel, M.D. Watson, L.M. Evans,
P.D.
Мента, К.
Spiegel,
Y.-M. Kuo,
A.E. Roher,
and
CA. Raby
........................ 118
Prospects for Noninvasive Imaging of Brain Amyloid
β
in Alzheimer s
Disease. By R.P.
Friedland,
J.
Shi, J.C. LaManna, M.A. Smith,
and G. Perry
................................................ 123
A Newly Formed Amyloidogenic Fragment due to a Stop Codon Mutation
Causes Familial British Dementia. By J. Ghiso, R.
Vidal,
A. Rostagno, S. Mead, T.
Révész,
G.
Plant, and B. Frangione
.. 129
Relationship between Severe Amyloid Angiopathy, Apolipoprotein
E
Genotype, and Vascular Lesions in Alzheimer s Disease. By
J.M. Olichney, L.A.
Hansen,
J.H.
Lee, C.R.
Hofstetter,
R. Katzman, and L.J.
Thal................................... 138
Plasma
β-
Amyloid
Peptide,
Transforming Growth
Factor-ßl,
and Risk for
Cerebral Amyloid Angiopathy. By STEVEN M.
GREENBERG,
Hyun-Soon Cho, Heather
С
O Donnell, Jonathan Rosand,
Alan Z. Segal, Linda H. Younkin, Steven G. Younkin, and
G. William
Rebeck
.......................................... 144
The Effect of Iron and Aluminum on Transferrin and Other Serum Proteins
as Revealed by Isoelectric Focusing Gel Electrophoresis. By
S.J. Van
Rensburg, M.E. Carstens,
F.C.V. Potocnik, and
J.J.F. Taljaard
.............................................. 150
Aß
Vasoactivity in Vivo. By Zhiming
Suo, George
Su, Andón
Płaczek,
Amy Kundtz, James Humphrey, Fiona Crawford, and
Mike
Mullan
............................................... 156
Cytochemistry of Intraplatelet Ca 1 1 Spots as a Peripheral Marker of Age-
related Brain Impairment. By Carlo Bertoni-Freddari, Tiziana
Casoli,
Patrizia Fattoretti, Luciano Galeazzi, Giuseppina Di
Stefano, Natascia Belardinelli, Eugenio
Pucci,
and
Mario Signorino
............................................ 164
Part IV. Apolipoprotein
E
and Genetics in Cerebral Amyloid
Angiopathy and Alzheimer s Disease
Lipoproteins in the Central Nervous System. By Mary Jo LaDu,
Catherine Reardon, Linda Van Eldik, Anne M.
Fagan,
Guoiun
Ви,
David Holtzman, and Godfrey S. Getz
........... 167
Apolipoprotein
E
Genotype and Cerebral Amyloid Angiopathy-related
Hemorrhage. By Mark O. McCarron and James A.R. Nicoll
...... 176
Apolipoprotein E, Smooth Muscle Cells and the Pathogenesis of Cerebral
Amyloid Angiopathy: the Potential Role of Impaired Cerebrovascular
Aß
Clearance. By
Reinhard
Prior,
Günther
WiHL, and
Britta Urmoneit............................................ 180
Amyloid-ß-induced
Degeneration of Human Brain Pericytes Is Dependent
on the Apolipoprotein
E
Genotype. By Marcel M.
Verbeek,
William E. Van Nostrand, Irene
Отге
-Höller,
Pieter
Wesseling, and Robert
M.W. de
Waal
....................... 187
Earlier Age of Onset of Alzheimer s Disease in Patients with Both the
Transferrin C2 and Apolipoprotein
Ε-ε4
Alíeles.
By S.J. VAN
Rensburg, F.C.V. Potocnik, J.N.P.
De
Villiers, M.J. Kotze, and
J.J.F. Taljaard
.............................................. 200
Inherent Abnormalities in Energy Metabolism in Alzheimer Disease:
Interaction with Cerebrovascular Compromise. By John P. Blass,
Rex Kwan-Fu Sheu, and Gary E. Gibson
...................... 204
Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid
Precursor Protein in Alzheimer s Disease Differ According to Apolipo-
protein-E Genotype. By Suzanne Craft, Sanjay Asthana,
Gerard
Schellenberg, Laura
Baker,
Monique Cherrier,
Adam A. Boyt, Ralph
N.
Martins, Murray
Raskind,
Elaine Peskind, and Stephen Plymate
........................ 222
Part
У.
VAD:
Clinical Aspects, Vascular Lesions, and Imaging
Interface between Vascular Dementia and Alzheimer Syndrome:
Nosologie
Redefinition. By
V. Olga
Emery, Edward X. Gillie, and
Joseph A. Smith
............................................. 229
Which Vascular Lesions Are of Importance in Vascular Dementia? By
Margaret M. Esiri
.......................................... 239
Severity of Cardiovascular Disease, Apolipoprotein
E
Genotype, and Brain
Pathology in Aging and Dementia. By
Irina Alafuzoff,
Seppo
Helisalmi,
Arto Mannermaa,
and Hilkka Soininen
............. 244
Can PET Data Differentiate Alzheimer s Disease from Vascular Dementia?
By Ken Nagata, Hiroshi Maruya, Hiromichi
Yuya, Hiroo
Terashi, Yasunori
Mito,
Haruhisa
Kato, Mika
Sato,
YuicHi Satoh, Yasuhito Watahiki, Yutaka Hirata,
Eriko
Yokoyama, and
Jun
Hatazawa
................................ 252
Limitations of Clincal Criteria for the Diagnosis of Vascular Dementia in
Clinical Trials: Is a Focus on
Subcortical
Vascular Dementia a
Solution? By
Timo Erkinjuntti, Domenico Inzitari,
Leonardo Pantoni, Anders Wallin, Philip Scheltens,
Kenneth
Rockwood,
and David W. Desmond
................. 262
Part VI. Vasculopathies and CADASIL
CADASIL: Hereditary Arteriopathy Leading to Multiple Brain Infarcts and
Dementia. By
Matti
Viitanen and Hannu
Kalimo
.............. 273
Skin Biopsy Value and Leukoaraiosis. By M.M. Ruchoux, P. Brulin,
E. Leteurtre, and C.A. Maurage
........................... 285
Hereditary Vascular Dementia Linked to Notch
3
Mutations: CADASIL in
British Families. By
N.J.
Thomas, CM. Morris, F. Scaravilli,
J. Johansson, M. Rossor, R.
De Lange,
D.
Ѕт
Clair,
J. Nicoll,
C.
Blank,
A.
Coulthard,
K. Bushby, P.G.
Ince, D.
Burn, and
R.N. Kalaria
................................................ 293
Linear Relation between Cerebral Phosphocreatine Concentration and
Memory Capacities during Permanent Brain Vessel Occlusions in Rats.
By Konstanze Plaschke, Seong-Wook Yun, Eike Martin,
Siegfried Hoyer, and Hubert J.
Bardenheuer.................. 299
Part
VIL Transgenic
Animal and In Vitro Models:
Vascular Effects
Mechanisms of Cerebrovascular Amyloid Deposition: Lessons from Mouse
Models. By Patrick
Burgermeister,
Michael E. Calhoun,
David T.
Winkler,
and
Mathias Jucker....................... 307
Alzheimer s Disease-like Cerebrovascular Pathology in Transforming
Growth Factor-
β
1
Transgenic Mice and Functional Metabolic
Correlates. By T. Wyss-Coray,
С
Lin, D.
Von
Euw, E. Masliah,
L. MUCKE, AND P. LACOMBE
................................... 317
The Role of Apolipoprotein
E in
the Deposition of
β-
Amyloid
Peptide
during Ischemia-Reperfusion Brain Injury: A Model of Early
Alzheimer s Disease. By
Ryszard Pluta...........................
324
Alterations of Alzheimer s Disease in the Cholesterol-fed Rabbit, Including
Vascular Inflammation: Preliminary Observations. By D. LARRY
Sparks, Yu-Min
Kuo, Alex Roher,
Tim Martin, and
Ronald J.
Lukas............................................. 335
Animal Model of Alzheimer-like Vascular Pathology and Inflammatory
Reaction. By J. Rhodin, T. Thomas, M. Bryant, and E.T. Sutton
. 345
Vascular Endothelium Is a Site of Free Radical Production and Inflammation
in Areas of
Neuronal
Loss in Thiamine-deficient Brain. By NOEL Y.
Calingasan and Gary E. Gibson
............................. 353
Marked Hippocampal
Neuronal
Damage without Motor Deficits after Mild
Concussive-like Brain Injury in Apolipoprotein E-deficient Mice. By
Seol-Heui Han and Seung-Yun Chung
........................ 357
Part
VIII.
Cholinergic Mechanisms and Vascular Pathology
Cortical Cholinergic Denervation Elicits Vascular
Aß
Deposition. By
Alex E.
Roher,
Yu-Min Kuo, Pamela E. Potter, Mark R.
Emmerling, Robert A. Durham, Douglas G. Walker,
Lucia
I. Sue, William G. Honer, and Thomas G. Beach
......... 366
β-
Amyloid Excitotoxicity in Rat Magnocellular Nucleus
Basalis:
Effect of
Cortical Deafferentation on Cerebral Blood Flow Regulation and
Implications for Alzheimer s Disease. By
Tibor Harkány,
Botond Penke,
and Paul
G.M. Luiten
......................... 374
Effect of a Memory-Enhancing Drug,
ΑΓΓ-082,
on the Level of Synapto-
physin. By D.K. Lahiri, Y.-W. Ge, and M.R. Farlow
............. 387
Differentiated Cerebrovascular Effects of Physostigmine and Tacrine in
Cortical Areas Deafferented from the Nucleus
Basalis Magnocellularis
Suggest Involvement of Basalocortical Projections to Microvessels. By
Philippe Peruzzi, Dominique Von
Euw, and Pierre Lacombe
... 394
Part IX. Cardiovascular Risk Factors and Vascular
Pathophysiology in Dementia
Plasma Total Homocysteine and Cognitive Performance in a Volunteer
Elderly Population. By M. BUDGE,
С
JOHNSTON,
E. HOGER VORST,
С.
de Jager, E. Milwain,
S.D.
Iversen,
L.
Barnetson,
E. King,
and
A.D.
Smith
.............................................. 407
Cardiovascular and Other Risk Factors for Alzheimer s Disease and
Vascular Dementia. By John S. Meyer, Gaiane M.
Rauch,
Ronald
A.
Rauch, Anwarul
Haque, and Kate Crawford
.............. 411
Critically Attained Threshold of Cerebral Hypoperfusion: Can It Cause
Alzheimer s Disease? By
J.C. DE LA
TORRE
........................ 424
The Renin Angiotensin System and Alzheimer s Disease. By PHILIPPE
AMOUYEL, Florence
Richard, Claudine Berr, Isabelle David-
Fromentin,
and Nicole Helbecque
........................... 437
Neurocardiovascular Instability, Hypotensive Episodes, and
MRI
Lesions in
Neurodegenerative
Dementia. By
Clive
Ballard,
John O Brien,
Bob Barber, Philip Scheltens, Fiona Shaw, Ian McKeith, and
Rose Anne Kenny
........................................... 442
β-
Amyloid Vasoactivity and
Proinflammation
in Microglia Can Be Blocked
by cGMP-Elevating Agents. By Daniel Paris, Terrence Town,
Timothy Parker, James Humphrey, and Michael
Mullan
........ 446
β-
Amyloid Fragment
25-35
Induces Changes in Cytosolic Free Calcium in
Human Platelets. By Luciano GaleaZZI, Tiziana Casoli,
Sergio
Giunta, Patrizia Fattoretti, Natascia
Gracciotti,
Ugo Caselli,
and Carlo Bertoni-Freddari
................... 451
Part X.
Wbite
Matter Lesions and Dementia
Vascular Involvement in Cognitive Decline and Dementia:
Epidemiologie
Evidence from the Rotterdam Study and the Rotterdam Scan Study.
By
Monique M.B.
Breteler
................................... 457
Relevance of White Matter Changes to
Pre-
and Poststroke Dementia.
By Florence Pasquier,
Hilde
Hénon,
and
Didier
Leys
......... 466
Corpus Callosum Measurement as an in Vivo Indicator for Neocortical
Neuronal
Integrity, but not White Matter Pathology, in Alzheimer s
Disease. By
Harald
Hampel, Stefan J. Teipel, Gene E. Alexander,
Barry Horwitz,
Pietro Pietrini,
Hanns Hippius, Hans-Jürgen
Möller,
Mark
В.
Schapiro, and Stanley I. Rapoport
............ 470
Contrast-enhanced
MRI
of White Matter Lesions in Patients with Blood-
Brain Barrier Dysfunction. By Lars-Olof Wahlund and
LENA BRONGE
................................................. 477
The Association between White Matter Lesions on Magnetic Resonance
Imaging and
Noncognitive
Symptoms. By John O Brien, Robert
Perry, Robert Barber, Anil Gholkar, and Alan Thomas
..... 482
Neuropathological Findings in the Very Old: Results from the First
101
Brains of a Population-based Longitudinal Study of Dementing
Disorders. By J.H. Xuereb,
С
Brayne,
С
Dufouil, H.
Gertz,
С.
WiscHiK,
С.
Harrington,
E. Mukaetova-Ladinska,
M.A. McGee, A. O Sullivan, D. O Connor, E.S. Paykel, and
F.A. Huppert
................................................ 490
Leukoaraiosis at Presentation and Disease Progression during Follow-up in
Histologically Confirmed Cases of Dementia. By R. Clarke,
C. Joachim, M. Esiri, J. Morris, H. Bungay, A. Molyneux,
M. Budge, C. Frost, E. King, L. Barnetson, and
A.D.
Smith
___ 497
Part XI. Diagnostic, Preventative, and Treatment Strategies
in Alzheimer s Disease and Vascular Dementia
Vascular Actions of Estrogen and Alzheimer s Disease. By T. Thomas and
J. Rhodin
.................................................... 501
Subcortical
Vascular Dementia as a Specific Target for Clinical Trials. By
Domenico Inzitari, Timo
Erkjnjuntti, Anders Wallin,
Teodoro
del
Ser,
Marco Romanelli,
and Leonardo Pantoni
.. 510
The Diagnosis of Mixed Dementia in the Consortium for the Investigation
of Vascular Impairment of Cognition (CIVIC). By K.
Rockwood,
C. MacKnight,
С
Wentzel, S. Black,
R. Bouchard, S. Gauthier,
H.
Feldman, d. Hogan,
A. Kertész,
and P. Montgomery for
the CIVIC Investigators
.................................... 522
Glial
Modulating and Neurotrophic Properties of Propentofylline and Its
Application to Alzheimer s Disease and Vascular Dementia. By
Garth E.
Ringheim.......................................... 529
Investigating the Natural Course and Treatment of Vascular Dementia and
Alzheimer s Disease: Parallel Study Populations in Two Randomized,
Placebo-Controlled Trials. By Barbara Kittner, Peter Paul
De Deyn,
and
Timo Erkinjuntti
................................ 535
Preliminary Results from an MRI/CT-Based Database for Vascular
Dementia and Alzheimer s Disease. By PHILIP SCHELTENS AND
Barbara Kittner
............................................ 542
Alzheimer s Disease and Vascular Dementia: Some Points of Confluence.
By
Hedda
Agüero-Torres
and
Bengt Winblad
................ 547
Index of Contributors
........................................... 553
Sponsorship was received from:
•
BAYER
AG
•
EISAI LIMITED
•
G.J.
LIV
ANOS
TRUST (ALZHEIMER S REPORTS)
• HOECHST
MARRION
ROUSSEL
•
JANSSEN PHARMACEimCA
•
NOVARTIS PHARMA
AG
• PARKE-DAVIS
•
PFIZER INC.
•
SMITH KLINE BEECHAM PHARMACEUTICALS
•
ZENECA
•
MEDICAL RESEARCH COUNCIL
•
INSTITUTE FOR BRAIN AND BLOOD VESSELS,
АКГГА
JAPAN
•
INSTITUTE FOR HEALTH OF THE ELDERLY
•
UNIVERSITY OF NEWCASTLE UPON TYNE
The New York Academy of Sciences believes it has a responsibility to provide an open
forum for discussion of scientific questions. The positions taken by the participants in
the reported conferences are their own and not necessarily those of the Academy. The
Academy has no intent to influence legislation by providing such forums.
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV013255900 |
callnumber-first | Q - Science |
callnumber-label | Q11 |
callnumber-raw | Q11 RC523 |
callnumber-search | Q11 RC523 |
callnumber-sort | Q 211 |
callnumber-subject | Q - General Science |
classification_rvk | YG 4037 |
ctrlnum | (OCoLC)43483720 (DE-599)BVBBV013255900 |
dewey-full | 616.8/3107 500 |
dewey-hundreds | 600 - Technology (Applied sciences) 500 - Natural sciences and mathematics |
dewey-ones | 616 - Diseases 500 - Natural sciences and mathematics |
dewey-raw | 616.8/3107 500 |
dewey-search | 616.8/3107 500 |
dewey-sort | 3616.8 43107 |
dewey-tens | 610 - Medicine and health 500 - Natural sciences and mathematics |
discipline | Allgemeine Naturwissenschaft Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03132nam a2200733 cb4500</leader><controlfield tag="001">BV013255900</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20000724 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">000718s2000 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1573312517</subfield><subfield code="9">1-57331-251-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1573312525</subfield><subfield code="9">1-57331-252-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)43483720</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013255900</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">Q11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC523</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.8/3107</subfield><subfield code="2">21</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">500</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 4037</subfield><subfield code="0">(DE-625)153494:12944</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vascular factors in Alzheimer's disease</subfield><subfield code="c">ed. by Raj N. Kalaria ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">New York Acad. of Sciences</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIX, 556 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">New York Academy of Sciences: Annals of the New York Academy of Sciences</subfield><subfield code="v">903</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Accidents vasculaires cérébraux - Physiopathologie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alzheimer, Maladie d' - Physiopathologie - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerveau - Vaisseaux sanguins - Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaatziekten</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ziekte van Alzheimer</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alzheimer Disease</subfield><subfield code="x">etiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alzheimer Disease</subfield><subfield code="x">physiopathology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Alzheimer's disease</subfield><subfield code="x">Pathophysiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Brain</subfield><subfield code="x">Blood-vessels</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebral Amyloid Angiopathy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebrovascular Disorders</subfield><subfield code="x">physiopathology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebrovascular disease</subfield><subfield code="x">Pathophysiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dementia</subfield><subfield code="x">etiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dementia</subfield><subfield code="x">physiopathology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Amyloidose</subfield><subfield code="0">(DE-588)4142314-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pathophysiologie</subfield><subfield code="0">(DE-588)4044898-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hirngefäßkrankheit</subfield><subfield code="0">(DE-588)4025015-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1999</subfield><subfield code="z">Newcastle-upon-Tyne</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pathophysiologie</subfield><subfield code="0">(DE-588)4044898-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hirngefäßkrankheit</subfield><subfield code="0">(DE-588)4025015-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pathophysiologie</subfield><subfield code="0">(DE-588)4044898-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Amyloidose</subfield><subfield code="0">(DE-588)4142314-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Hirngefäßkrankheit</subfield><subfield code="0">(DE-588)4025015-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kalaria, Raj N.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">New York Academy of Sciences: Annals of the New York Academy of Sciences</subfield><subfield code="v">903</subfield><subfield code="w">(DE-604)BV002532608</subfield><subfield code="9">903</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung TU Muenchen</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009035838&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009035838</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1999 Newcastle-upon-Tyne gnd-content |
genre_facet | Konferenzschrift 1999 Newcastle-upon-Tyne |
id | DE-604.BV013255900 |
illustrated | Illustrated |
indexdate | 2024-07-09T18:42:35Z |
institution | BVB |
isbn | 1573312517 1573312525 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009035838 |
oclc_num | 43483720 |
open_access_boolean | |
owner | DE-20 DE-12 DE-355 DE-BY-UBR DE-578 |
owner_facet | DE-20 DE-12 DE-355 DE-BY-UBR DE-578 |
physical | XIX, 556 S. Ill., graph. Darst. |
publishDate | 2000 |
publishDateSearch | 2000 |
publishDateSort | 2000 |
publisher | New York Acad. of Sciences |
record_format | marc |
series | New York Academy of Sciences: Annals of the New York Academy of Sciences |
series2 | New York Academy of Sciences: Annals of the New York Academy of Sciences |
spelling | Vascular factors in Alzheimer's disease ed. by Raj N. Kalaria ... New York, NY New York Acad. of Sciences 2000 XIX, 556 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier New York Academy of Sciences: Annals of the New York Academy of Sciences 903 Accidents vasculaires cérébraux - Physiopathologie - Congrès Alzheimer, Maladie d' - Physiopathologie - Congrès Cerveau - Vaisseaux sanguins - Congrès Vaatziekten gtt Ziekte van Alzheimer gtt Alzheimer Disease etiology Congresses Alzheimer Disease physiopathology Congresses Alzheimer's disease Pathophysiology Congresses Brain Blood-vessels Congresses Cerebral Amyloid Angiopathy Congresses Cerebrovascular Disorders physiopathology Congresses Cerebrovascular disease Pathophysiology Congresses Dementia etiology Congresses Dementia physiopathology Congresses Alzheimerkrankheit (DE-588)4112510-1 gnd rswk-swf Amyloidose (DE-588)4142314-8 gnd rswk-swf Pathophysiologie (DE-588)4044898-8 gnd rswk-swf Hirngefäßkrankheit (DE-588)4025015-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1999 Newcastle-upon-Tyne gnd-content Alzheimerkrankheit (DE-588)4112510-1 s Pathophysiologie (DE-588)4044898-8 s DE-604 Hirngefäßkrankheit (DE-588)4025015-5 s Amyloidose (DE-588)4142314-8 s Kalaria, Raj N. Sonstige oth New York Academy of Sciences: Annals of the New York Academy of Sciences 903 (DE-604)BV002532608 903 Digitalisierung TU Muenchen application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009035838&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Vascular factors in Alzheimer's disease New York Academy of Sciences: Annals of the New York Academy of Sciences Accidents vasculaires cérébraux - Physiopathologie - Congrès Alzheimer, Maladie d' - Physiopathologie - Congrès Cerveau - Vaisseaux sanguins - Congrès Vaatziekten gtt Ziekte van Alzheimer gtt Alzheimer Disease etiology Congresses Alzheimer Disease physiopathology Congresses Alzheimer's disease Pathophysiology Congresses Brain Blood-vessels Congresses Cerebral Amyloid Angiopathy Congresses Cerebrovascular Disorders physiopathology Congresses Cerebrovascular disease Pathophysiology Congresses Dementia etiology Congresses Dementia physiopathology Congresses Alzheimerkrankheit (DE-588)4112510-1 gnd Amyloidose (DE-588)4142314-8 gnd Pathophysiologie (DE-588)4044898-8 gnd Hirngefäßkrankheit (DE-588)4025015-5 gnd |
subject_GND | (DE-588)4112510-1 (DE-588)4142314-8 (DE-588)4044898-8 (DE-588)4025015-5 (DE-588)1071861417 |
title | Vascular factors in Alzheimer's disease |
title_auth | Vascular factors in Alzheimer's disease |
title_exact_search | Vascular factors in Alzheimer's disease |
title_full | Vascular factors in Alzheimer's disease ed. by Raj N. Kalaria ... |
title_fullStr | Vascular factors in Alzheimer's disease ed. by Raj N. Kalaria ... |
title_full_unstemmed | Vascular factors in Alzheimer's disease ed. by Raj N. Kalaria ... |
title_short | Vascular factors in Alzheimer's disease |
title_sort | vascular factors in alzheimer s disease |
topic | Accidents vasculaires cérébraux - Physiopathologie - Congrès Alzheimer, Maladie d' - Physiopathologie - Congrès Cerveau - Vaisseaux sanguins - Congrès Vaatziekten gtt Ziekte van Alzheimer gtt Alzheimer Disease etiology Congresses Alzheimer Disease physiopathology Congresses Alzheimer's disease Pathophysiology Congresses Brain Blood-vessels Congresses Cerebral Amyloid Angiopathy Congresses Cerebrovascular Disorders physiopathology Congresses Cerebrovascular disease Pathophysiology Congresses Dementia etiology Congresses Dementia physiopathology Congresses Alzheimerkrankheit (DE-588)4112510-1 gnd Amyloidose (DE-588)4142314-8 gnd Pathophysiologie (DE-588)4044898-8 gnd Hirngefäßkrankheit (DE-588)4025015-5 gnd |
topic_facet | Accidents vasculaires cérébraux - Physiopathologie - Congrès Alzheimer, Maladie d' - Physiopathologie - Congrès Cerveau - Vaisseaux sanguins - Congrès Vaatziekten Ziekte van Alzheimer Alzheimer Disease etiology Congresses Alzheimer Disease physiopathology Congresses Alzheimer's disease Pathophysiology Congresses Brain Blood-vessels Congresses Cerebral Amyloid Angiopathy Congresses Cerebrovascular Disorders physiopathology Congresses Cerebrovascular disease Pathophysiology Congresses Dementia etiology Congresses Dementia physiopathology Congresses Alzheimerkrankheit Amyloidose Pathophysiologie Hirngefäßkrankheit Konferenzschrift 1999 Newcastle-upon-Tyne |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009035838&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV002532608 |
work_keys_str_mv | AT kalariarajn vascularfactorsinalzheimersdisease |